Amgen Inc. Amortization of Intangible Assets
Amgen Inc. (AMGN) reported Amortization of Intangible Assets of $890.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2026-08-05
- Amgen Inc. amortization of intangible assets for the quarter ending 2026-06-30 was $890.00M, a 19.09% decline year-over-year.
- Amgen Inc. amortization of intangible assets for the quarter ending 2026-03-31 was $896.00M, a 25.33% decline year-over-year.
- Amgen Inc. amortization of intangible assets for the quarter ending 2025-12-31 was $900.00M, a 25.00% decline year-over-year.
- Amgen Inc. amortization of intangible assets for the quarter ending 2025-09-30 was $1.10B, a 8.33% decline year-over-year.
- Amgen Inc. amortization of intangible assets for fiscal 2025 was $4.30B, a 10.42% decline from fiscal 2024.
- Amgen Inc. amortization of intangible assets for fiscal 2024 was $4.80B, a 50.00% increase from fiscal 2023.
- Amgen Inc. amortization of intangible assets for fiscal 2023 was $3.20B, a 23.08% increase from fiscal 2022.
- Amgen Inc. amortization of intangible assets for fiscal 2022 was $2.60B, a 0.00% change from fiscal 2021.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 9 month as first filed | Amortization of Intangible Assets 12 month | Amortization of Intangible Assets 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $890.00M 10-Q · filed 2026-08-05 | $1.80B 10-Q · filed 2026-08-05 | $2.69B derived: sum of 3 quarters · filed 2026-08-05 | $3.79B derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2026-03-31 | $896.00M 10-Q · filed 2026-05-01 | $1.80B derived: sum of 2 quarters · filed 2026-05-01 | $2.90B derived: sum of 3 quarters · filed 2026-05-01 | $4.00B derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2025-12-31 | $900.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $2.00B derived: sum of 2 quarters · filed 2026-02-13 | $3.10B derived: sum of 3 quarters · filed 2026-08-05 | $4.30B 10-K · filed 2026-02-13 | ||
| 2025-09-30 | $1.10B 10-Q · filed 2025-11-05 | $2.20B derived: sum of 2 quarters · filed 2026-08-05 | $3.40B 10-Q · filed 2025-11-05 | $4.60B derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2025-06-30 | $1.10B 10-Q · filed 2026-08-05 | $2.30B 10-Q · filed 2026-08-05 | $3.50B derived: sum of 3 quarters · filed 2026-08-05 | $4.70B derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2025-03-31 | $1.20B 10-Q · filed 2026-05-01 | $2.40B derived: sum of 2 quarters · filed 2026-05-01 | $3.60B derived: sum of 3 quarters · filed 2026-05-01 | $4.80B derived: sum of 4 quarters · filed 2026-05-01 | ||
| 2024-12-31 | $1.20B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $2.40B derived: sum of 2 quarters · filed 2026-02-13 | $3.60B derived: sum of 3 quarters · filed 2026-02-13 | $4.80B 10-K · filed 2026-02-13 | ||
| 2024-09-30 | $1.20B 10-Q · filed 2025-11-05 | $2.40B derived: sum of 2 quarters · filed 2025-11-05 | $3.60B 10-Q · filed 2025-11-05 | $4.70B derived: sum of 4 quarters · filed 2026-02-13 | ||
| 2024-06-30 | $1.20B 10-Q · filed 2025-08-06 | $2.40B 10-Q · filed 2025-08-06 | $3.50B derived: sum of 3 quarters · filed 2026-02-13 | $4.19B derived: sum of 4 quarters · filed 2026-02-13 | ||
| 2024-03-31 | $1.20B 10-Q · filed 2025-05-02 | $2.30B derived: sum of 2 quarters · filed 2026-02-13 | $2.99B derived: sum of 3 quarters · filed 2026-02-13 | $3.69B derived: sum of 4 quarters · filed 2026-02-13 | ||
| 2023-12-31 | $1.10B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $1.79B derived: sum of 2 quarters · filed 2026-02-13 | $2.49B derived: sum of 3 quarters · filed 2026-02-13 | $3.20B 10-K · filed 2026-02-13 | ||
| 2023-09-30 | $693.00M 10-Q · filed 2024-10-31 | $1.39B derived: sum of 2 quarters · filed 2024-10-31 | $2.10B 10-Q · filed 2024-10-31 | $2.78B derived: sum of 4 quarters · filed 2025-02-14 | ||
| 2023-06-30 | $693.00M 10-Q · filed 2024-08-07 | $1.40B 10-Q · filed 2024-08-07 | $2.09B derived: sum of 3 quarters · filed 2025-02-14 | $2.71B derived: sum of 4 quarters · filed 2025-02-14 | ||
| 2023-03-31 | $693.00M 10-Q · filed 2024-05-03 | $1.39B derived: sum of 2 quarters · filed 2025-02-14 | $2.02B derived: sum of 3 quarters · filed 2025-02-14 | $2.65B derived: sum of 4 quarters · filed 2025-02-14 | ||
| 2022-12-31 | $700.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14 | $1.33B derived: sum of 2 quarters · filed 2025-02-14 | $1.96B derived: sum of 3 quarters · filed 2025-02-14 | $2.60B 10-K · filed 2025-02-14 | ||
| 2022-09-30 | $628.00M 10-Q · filed 2023-10-31 | $1.26B derived: sum of 2 quarters · filed 2023-10-31 | $1.90B 10-Q · filed 2023-10-31 | $2.59B derived: sum of 4 quarters · filed 2024-02-14 | ||
| 2022-06-30 | $629.00M 10-Q · filed 2023-08-04 | $1.30B 10-Q · filed 2023-08-04 | $1.97B derived: sum of 3 quarters · filed 2024-02-14 | $2.61B derived: sum of 4 quarters · filed 2024-02-14 | ||
| 2022-03-31 | $637.00M 10-Q · filed 2023-04-28 | $1.34B derived: sum of 2 quarters · filed 2024-02-14 | $1.98B derived: sum of 3 quarters · filed 2024-02-14 | $2.63B derived: sum of 4 quarters · filed 2024-02-14 | ||
| 2021-12-31 | $700.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $1.34B derived: sum of 2 quarters · filed 2024-02-14 | $1.99B derived: sum of 3 quarters · filed 2024-02-14 | $2.60B 10-K · filed 2024-02-14 | ||
| 2021-09-30 | $642.00M 10-Q · filed 2022-11-04 | $1.29B derived: sum of 2 quarters · filed 2022-11-04 | $1.90B 10-Q · filed 2022-11-04 | $2.65B derived: sum of 4 quarters · filed 2023-02-09 | ||
| 2021-06-30 | $652.00M 10-Q · filed 2022-08-05 | $1.30B 10-Q · filed 2022-08-05 | $2.01B derived: sum of 3 quarters · filed 2023-02-09 | $2.71B derived: sum of 4 quarters · filed 2023-02-09 | ||
| 2021-03-31 | $654.00M 10-Q · filed 2022-04-28 | $1.35B derived: sum of 2 quarters · filed 2023-02-09 | $2.06B derived: sum of 3 quarters · filed 2023-02-09 | $2.77B derived: sum of 4 quarters · filed 2023-02-09 | ||
| 2020-12-31 | $700.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-09 | $1.41B derived: sum of 2 quarters · filed 2023-02-09 | $2.12B derived: sum of 3 quarters · filed 2023-02-09 | $2.80B 10-K · filed 2023-02-09 | ||
| 2020-09-30 | $708.00M 10-Q · filed 2021-11-03 | $1.42B derived: sum of 2 quarters · filed 2021-11-03 | $2.10B 10-Q · filed 2021-11-03 | $2.58B derived: sum of 4 quarters · filed 2022-02-16 | ||
| 2020-06-30 | $713.00M 10-Q · filed 2021-08-04 | $1.40B 10-Q · filed 2021-08-04 | $1.87B derived: sum of 3 quarters · filed 2022-02-16 | $2.19B derived: sum of 4 quarters · filed 2022-02-16 | ||
| 2020-03-31 | $709.00M 10-Q · filed 2021-04-28 | $1.16B derived: sum of 2 quarters · filed 2022-02-16 | $1.48B derived: sum of 3 quarters · filed 2022-02-16 | $1.79B derived: sum of 4 quarters · filed 2022-02-16 | ||
| 2019-12-31 | $452.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | $770.00M derived: sum of 2 quarters · filed 2022-02-16 | $1.08B derived: sum of 3 quarters · filed 2022-02-16 | $1.40B 10-K · filed 2022-02-16 | ||
| 2019-09-30 | $318.00M 10-Q · filed 2020-10-29 | $633.00M derived: sum of 2 quarters · filed 2020-10-29 | $948.00M 10-Q · filed 2020-10-29 | $1.26B derived: sum of 4 quarters · filed 2021-02-09 | ||
| 2019-06-30 | $315.00M 10-Q · filed 2020-07-29 | $630.00M 10-Q · filed 2020-07-29 | $947.00M derived: sum of 3 quarters · filed 2021-02-09 | $1.28B derived: sum of 4 quarters · filed 2021-02-09 | ||
| 2019-03-31 | $315.00M 10-Q · filed 2020-05-01 | $632.00M derived: sum of 2 quarters · filed 2021-02-09 | $963.00M derived: sum of 3 quarters · filed 2021-02-09 | $1.29B derived: sum of 4 quarters · filed 2021-02-09 | ||
| 2018-12-31 | $317.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-09 | $648.00M derived: sum of 2 quarters · filed 2021-02-09 | $980.00M derived: sum of 3 quarters · filed 2021-02-09 | $1.30B 10-K · filed 2021-02-09 | ||
| 2018-09-30 | $331.00M 10-Q · filed 2019-10-30 | $663.00M derived: sum of 2 quarters · filed 2019-10-30 | $983.00M 10-Q · filed 2019-10-30 | $1.18B derived: sum of 4 quarters · filed 2020-02-12 | ||
| 2018-06-30 | $332.00M 10-Q · filed 2019-07-31 | $652.00M 10-Q · filed 2019-07-31 | $852.00M derived: sum of 3 quarters · filed 2020-02-12 | $1.16B derived: sum of 4 quarters · filed 2020-02-12 | ||
| 2018-03-31 | $320.00M 10-Q · filed 2019-05-01 | $520.00M derived: sum of 2 quarters · filed 2020-02-12 | $828.00M derived: sum of 3 quarters · filed 2020-02-12 | $1.20B derived: sum of 4 quarters · filed 2020-02-12 | ||
| 2017-12-31 | $200.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-12 | $508.00M derived: sum of 2 quarters · filed 2020-02-12 | $879.00M derived: sum of 3 quarters · filed 2020-02-12 | $1.30B 10-K · filed 2020-02-12 | ||
| 2017-09-30 | $308.00M 10-Q · filed 2018-10-31 | $679.00M derived: sum of 2 quarters · filed 2018-10-31 | $1.10B 10-Q · filed 2018-10-31 | $1.45B derived: sum of 4 quarters · filed 2019-02-13 | ||
| 2017-06-30 | $371.00M 10-Q · filed 2018-07-27 | $744.00M 10-Q · filed 2018-07-27 | $1.14B derived: sum of 3 quarters · filed 2019-02-13 | $1.51B derived: sum of 4 quarters · filed 2019-02-13 | ||
| 2017-03-31 | $373.00M 10-Q · filed 2018-04-25 | $773.00M derived: sum of 2 quarters · filed 2019-02-13 | $1.14B derived: sum of 3 quarters · filed 2019-02-13 | $1.51B derived: sum of 4 quarters · filed 2019-02-13 | ||
| 2016-12-31 | $400.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-13 | $771.00M derived: sum of 2 quarters · filed 2019-02-13 | $1.14B derived: sum of 3 quarters · filed 2019-02-13 | $1.50B 10-K · filed 2019-02-13 | ||
| 2016-09-30 | $371.00M 10-Q · filed 2017-10-26 | $742.00M derived: sum of 2 quarters · filed 2017-10-26 | $1.10B 10-Q · filed 2017-10-26 | $1.51B derived: sum of 4 quarters · filed 2018-02-13 | ||
| 2016-06-30 | $371.00M 10-Q · filed 2017-07-26 | $740.00M 10-Q · filed 2017-07-26 | $1.14B derived: sum of 3 quarters · filed 2018-02-13 | $1.48B derived: sum of 4 quarters · filed 2018-02-13 | ||
| 2016-03-31 | $369.00M 10-Q · filed 2017-04-27 | $769.00M derived: sum of 2 quarters · filed 2018-02-13 | $1.11B derived: sum of 3 quarters · filed 2018-02-13 | $1.45B derived: sum of 4 quarters · filed 2018-02-13 | ||
| 2015-12-31 | $400.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | $740.00M derived: sum of 2 quarters · filed 2018-02-13 | $1.08B derived: sum of 3 quarters · filed 2018-02-13 | $1.40B 10-K · filed 2018-02-13 | ||
| 2015-09-30 | $340.00M 10-Q · filed 2016-10-28 | $685.00M derived: sum of 2 quarters · filed 2016-10-28 | $1.00B 10-Q · filed 2016-10-28 | $1.43B derived: sum of 4 quarters · filed 2017-02-14 | ||
| 2015-06-30 | $345.00M 10-Q · filed 2016-07-29 | $686.00M 10-Q · filed 2016-07-29 | $1.09B derived: sum of 3 quarters · filed 2017-02-14 | $1.43B derived: sum of 4 quarters · filed 2017-02-14 | ||
| 2015-03-31 | $341.00M 10-Q · filed 2016-05-02 | $741.00M derived: sum of 2 quarters · filed 2017-02-14 | $1.08B derived: sum of 3 quarters · filed 2017-02-14 | $1.42B derived: sum of 4 quarters · filed 2017-02-14 | ||
| 2014-12-31 | $400.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | $739.00M derived: sum of 2 quarters · filed 2017-02-14 | $1.08B derived: sum of 3 quarters · filed 2017-02-14 | $1.40B 10-K · filed 2017-02-14 | $1.38B 10-K · filed 2015-02-19 | |
| 2014-09-30 | $339.00M 10-Q · filed 2015-11-02 | $680.00M derived: sum of 2 quarters · filed 2015-11-02 | $1.00B 10-Q · filed 2015-11-02 | $1.04B 10-Q · filed 2014-10-29 | $1.33B derived: sum of 4 quarters · filed 2016-10-31 | |
| 2014-06-30 | $341.00M 10-Q · filed 2015-08-05 | $698.00M 10-Q · filed 2015-08-05 | $987.00M derived: sum of 3 quarters · filed 2016-10-31 | $1.10B derived: sum of 4 quarters · filed 2016-10-31 | ||
| 2014-03-31 | $357.00M 10-Q · filed 2015-04-27 | $646.00M derived: sum of 2 quarters · filed 2016-10-31 | $763.00M derived: sum of 3 quarters · filed 2016-10-31 | $882.00M derived: sum of 4 quarters · filed 2016-10-31 | ||
| 2013-12-31 | $289.00M derived: 8-K 12 month − 10-Q 9 month · filed 2016-10-31 | $406.00M derived: sum of 2 quarters · filed 2016-10-31 | $525.00M derived: sum of 3 quarters · filed 2016-10-31 | $642.00M 8-K · filed 2016-10-31 | ||
| 2013-09-30 | $117.00M 10-Q · filed 2014-10-29 | $236.00M derived: sum of 2 quarters · filed 2014-10-29 | $353.00M 10-Q · filed 2014-10-29 | |||
| 2013-06-30 | $119.00M 10-Q · filed 2014-08-05 | $236.00M 10-Q · filed 2014-08-05 | ||||
| 2013-03-31 | $117.00M 10-Q · filed 2014-04-30 | |||||
| 2012-12-31 | $397.00M 10-K · filed 2015-02-19 | |||||
| 2011-12-31 | $380.00M 10-K · filed 2014-02-24 | |||||
| 2010-12-31 | $423.00M 10-K · filed 2013-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GILEAD SCIENCES, INC. (GILD) | United States | $185.522B | -48.37 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |